本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Blueprint Medicines Corporation

97.17
-1.5900-1.61%
盤後97.170.00000.00%16:08 EDT
成交量:62.17萬
成交額:6,126.74萬
市值:62.75億
市盈率:-39.61
高:101.34
開:100.04
低:97.08
收:98.76
資料載入中...
2021/11/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/29

重要事件披露

8-K - Current report
2021/07/29

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/28

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/06/04

重要事件披露

8-K - Current report
2021/05/17

重要事件披露

8-K - Current report
2021/04/29

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/29

重要事件披露

8-K - Current report
2021/04/12

重要事件披露

8-K - Current report
2021/02/17

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/17

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals